PARIS: Atos International has signed an agreement to acquire In Fidem, a Canada-based specialized cybersecurity consulting firm, a news release said. The closing of the transaction is expected to take place in Q1 2021. This acquisition will reinforce Atos’ position as the #3 worldwide cybersecurity services leader and in particular enhance its North America cybersecurity…
All posts in Euronext
Lysogene gets MHRA and Research Ethics Committee approvals for Gene Therapy Clinical Trial in the UK
PARIS: Lysogene, a phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, has received MHRA and Research Ethics Committee approvals to initiate the gene therapy clinical trial in the United Kingdom with LYS-GM101 for the treatment of GM1 gangliosidosis, a serious, pediatric, life threatening disease. LYS-GM101 builds on Lysogene’s extensive experience in…
Total acquires Fonroche Biogaz to become French leader in renewable gas
PARIS: Total SE announced the acquisition of Fonroche Biogaz, a company that designs, builds and operates anaerobic digestion units in France. With close to 500 gigawatt-hours (GWh) of installed capacity, which doubled between 2019 and 2020, Fonroche Biogaz is today the French market leader in the production of renewable gas1 with more than 10% market…
Sanofi to acquire Kymab for an upfront payment of approximately $1.1 billion
PARIS: Sanofi and Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immune-mediated diseases and immuno-oncology therapeutics, have entered into an agreement under which Sanofi will acquire Kymab for an upfront payment of approximately $1.1 billion and up to $350 million upon achievement of certain milestones. Under the terms of…
Valneva appoints Perry Celentano as interim COO, David Lawrence as acting CFO
SAINT-HERBLAIN: Valneva SE a specialty vaccine company focused on prevention against diseases with major unmet needs, has appointed Perry Celentano as Chief Operating Officer (COO) on an interim basis to support the expansion of the manufacturing sites in Livingston and Solna. Perry Celentano has an extensive track record in the pharma and vaccines industry including…
Nanobiotix announces key development milestones for 2021 after successful Nasdaq IPO
PARIS: Nanobiotix announced its global development plan for 2021 and beyond. Nanobiotix is a clinical-stage biotechnology company focused on developing first-in-class product candidates that use proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy and increasing the proportion of patients that respond to immune checkpoint inhibitors. “Following the successful closing of our…
Celyad Oncology signs $40 million equity purchase agreement with Lincoln Park Capital
BRUSSELS: Celyad Oncology SA has entered into a committed equity purchase agreement for up to $40 million with Lincoln Park Capital Fund LLC, a Chicago-based institutional investor. Over the 24-month term of the Purchase Agreement, the Company will have the right to direct LPC to purchase up to an aggregate amount of $40 million American…
Advicenne hires Peter Meeus as Chief Executive Officer
PARIS: Advicenne announced the appointment of Peter Meeus as Chief Executive Officer of Advicenne, effective February 15, 2021. Dr. André Ulmann, who has been serving as interim CEO, will assume the position of Chief Medical Officer of the Company. “I am very pleased to welcome Peter Meeus as our new CEO. Peter brings an extensive…
Heijmans sells 95 rental apartments in Noorderhaven project in Zutphen
AMSTERDAM: Heijmans has reached agreement with housing corporation Habion on the sale of ground and the realisation of 95 rental apartments in the Noorderhaven development in Zutphen. The start of construction is scheduled for Q2 2021. Heijmans’ share of the project represents a value of around € 27.5 million. Care apartments and liberalised sector rentals:…
Total will develop the LNG market in Benin
PARIS–(BUSINESS WIRE)– Total, the Republic of Benin and the Société Béninoise d’Energie Electrique (SBEE) have signed the Gas Supply Agreement and the Host Government Agreement for the development of LNG market, which will include a Liquefied Natural Gas (LNG) import floating terminal and the supply of up to 0.5 million tonnes per annum (Mtpa) of…
Lonza expands Bioconjugation facility and announces approval of third commercial ADC
BASEL, SWITZERLAND: Lonza has announced the start of expansion to its bioconjugation facility in Visp, Switzerland together with the successful commercial approval of a third antibody-drug-conjugate (ADC) produced at the site. Building on 12 years of experience in the exacting bioconjugation space, Lonza’s expansion will meet the development and manufacturing needs of pharma and biotech…